Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 May 2024 | Story Valentino Ndaba | Photo iStock
Africa Reparation Hub Launch 2024
Join us as we unite to confront the challenges of our past and pave the way for a more just and equitable future for all Africans.

The Department of Public Law at the University of the Free State’s (UFS) Faculty of Law is proud to announce the launch of the UFS Africa Reparation Hub alongside a colloquium centred around the theme Unifying Africa for Action to Advance Reparatory Justice.

Date: 6 June 2024

Time: 11:00-16:00

Venue : Microsoft Teams; join the event here

Click to view documentClick here to RSVP and here for more information and speakers.

The pursuit of reparations for historical and contemporary injustices in Africa has gathered significant momentum. From the adoption of the African Union resolution advocating a united front to the push for reparations of past atrocities, the continent is asserting its demand for justice. This drive traces its roots back to historical landmarks like the Abuja Proclamation of 1993 and the Durban Declaration and Programme of Action in 2001.

Launch of the hub

Aligned with the UFS Vision 130, the university has established the UFS Africa Reparation Hub to serve as a nucleus for frank discussions on Africa's reparations. It houses a comprehensive database of resources on the subject and is poised to host expert groups dedicated to furthering the cause.

The Colloquium

The faculty invites academics, policymakers, human rights advocates, justice professionals, and representatives from international, regional, and national bodies to the colloquium which will precede the launch of the hub. This virtual gathering aims to foster dialogue and action toward reparatory justice in Africa. Thereafter, attendees will witness the official launch of the UFS Africa Reparation Hub, marking a significant step forward in the continent’s journey towards healing and restitution.

Leading voices on reparatory justice

In an eagerly awaited keynote address, Prof Verene Shepherd, the esteemed Director of the Centre for Reparations Research at the University of West Indies, Jamaica, is poised to set the stage for a thought-provoking discussion on reparatory justice. Joining her will be a distinguished line-up of speakers including Prof Serges Kamga (Dean of the Faculty of Law at the UFS); Martin Okumu-Masiga (Secretary-General of the Africa Judges and Jurists Forum); Dr Ahmed Bugri (Senior Expert and Coordinator for Reparatory Justice and Racial Healing at the African Union); and Prof Kula Theletsane (Director of the Organ on Politics, Defence, and Security Affairs in Southern African Development Community (SADC).

Dr Catherine Namakula, Convenor of the Africa Reparation Hub, is anticipated to moderate the discussion, guiding the conversation towards actionable strategies for advancing reparations and fostering racial healing across Africa and beyond.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept